DepYmed key facts
as of Oct 2026- Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases.
- DepYmed is valued at approximately $36.3M as of Oct 2026 (last reported valuation).
- It has raised $14.3M across 6 recorded rounds; the latest was Seed Round ($250K) in Apr 2025.
- Notable investors include Accelerate Long Island, Cold Spring Harbor Laboratory, Jove Equity Partners, Long Island Emerging Technologies Fund, Long Island Emerging Technologies Fund (LIETF) — 8 tracked in total.
- DepYmed has filed 6 Form Ds with the SEC since 2021, most recently Apr 2025 ($250K sold to 1 investors).
- Status: Privately Held (backing).
DepYmed's last reported valuation, Apr 2021. Nothing priced has surfaced since.
- ·Watch DepYmed: the Monday email on marks, rounds and moves
DepYmed funding rounds
6 roundsDepYmed valuation
DepYmed's last reported valuation was $36.3 million in Apr 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has DepYmed raised?
DepYmed has raised $14.3 million across 6 recorded rounds since 2021. The largest was a $600,000 seed round in Aug 2024; the most recent was a $250,000 seed round in Apr 2025.
DepYmed has filed 6 Form Ds with the SEC since 2021, most recently in Apr 2025 ($250,000 sold to 1 investor).
DepYmed investors
8 investors are on record for DepYmed, including Accelerate Long Island, Cold Spring Harbor Laboratory, Jove Equity Partners and Long Island Emerging Technologies Fund. The seed round in Apr 2025 drew 1 investor.
About DepYmed
Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. The company develops novel small-molecule phosphatase inhibitors and copper-chelating compounds targeting protein tyrosine phosphatases, with applications across cancer, Wilson's Disease, Rett Syndrome, and other metabolic and rare disease indications, enabling pharmaceutical and biotechnology stakeholders to advance therapeutic candidates into clinical development.
- Sector
- Healthcare
- HQ
- Farmingdale, NY, United States
- Founded
- 2014
- Employees
- 2
- Website
- depymed.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.